Theravance Biopharma, Inc. (TBPH)
NASDAQ: TBPH · IEX Real-Time Price · USD
9.57
-0.11 (-1.14%)
At close: Jul 19, 2024, 4:00 PM
9.56
-0.01 (-0.10%)
Pre-market: Jul 20, 2024, 9:29 AM EDT
Theravance Biopharma Market Cap
Theravance Biopharma has a market cap or net worth of $465.42 million as of July 22, 2024. Its market cap has decreased by -21.59% in one year.
Market Cap
465.42M
Enterprise Value
412.51M
1-Year Change
-21.59%
Ranking
Category
Stock Price
$9.57
Market Cap Chart
Since May 16, 2014, Theravance Biopharma's market cap has decreased from $740.70M to $465.42M, a decrease of -37.16%. That is a compound annual growth rate of -4.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 465.40M | -16.85% |
| Dec 29, 2023 | 559.70M | -25.95% |
| Dec 30, 2022 | 755.80M | -7.20% |
| Dec 31, 2021 | 814.40M | -28.37% |
| Dec 31, 2020 | 1.14B | -22.64% |
| Dec 31, 2019 | 1.47B | 3.64% |
| Dec 31, 2018 | 1.42B | -6.02% |
| Dec 29, 2017 | 1.51B | -8.88% |
| Dec 30, 2016 | 1.66B | 166.99% |
| Dec 31, 2015 | 620.20M | 28.99% |
| Dec 31, 2014 | 480.80M | -35.09% |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Fate Therapeutics | 486.06M |
| biote | 485.75M |
| Third Harmonic Bio | 483.61M |
| Cassava Sciences | 483.60M |
| Enhabit | 475.98M |
| Anavex Life Sciences | 463.84M |
| MaxCyte | 459.99M |
| EyePoint Pharmaceuticals | 458.34M |